Scientific Milestones:

• The creation of a Gene Bank for the prevention of Alzheimer’s in the population at risk.
• The patenting of the world’s first Genetic Kit for the molecular diagnosis of Alzheimer’s disease.
• EuroEspes’ most important contribution over these years has been the accomplishment of the first pharmacogenomic studies of Alzheimer’s disease.
• EuroEspes has been at the forefront over the last fifteen years with over 1,500 scientific contributions on the etiopathogeny and treatment of degenerative diseases of the Central Nervous System. This makes EuroEspes one of the most productive scientific groups in the European Union.

Therapeutic Milestones:

• The launching of a highly precise Diagnostic Protocol with over 95% reliability  for diseases of the Nervous System, which has been exported to other countries.
• The development of the first Multifactorial Treatment, with superior results to those obtained with any other monotherapy for Alzheimer’s disease, and at a lower cost.
• Being at the forefront of the development of new first choice drugs for the treatment of Alzheimer’s disease over the last fifteen years.
• EuroEspes is one of the groups in Spain which has contributed most to innovation in the Pharmacological field for disorders of the Central Nervous System.

See Most Common Pathologies

Origin of our Patients